J-H Lin - JoVE Visualize

Showing results (401-410 of 421) with videos related to

Pageof 43

Sort By:

Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|June 9, 2017

[Efficacy and safety of oseltamivir in children with suspected influenza: a multicenter randomized open-label trial]C H He, C Y Liu, G Y Lin, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1996

Species and organ differences in first-pass metabolism of the ester prodrug L-751,164 in dogs and monkeys. In vivo and in vitro studiesT Prueksaritanont, L M Gorham, J D Ellis, et al.

Zhonghua Fu Chan Ke Za Zhi|November 25, 2021

[Comparative analysis of high risk factors between early-onset pre-eclampsia and late-onset pre-eclampsia]X Lyu, W Y Zhang, J X Zhang, et al.

Journal of Medical Genetics|March 31, 2006

Functional and clinical characterization of a mutation in KCNJ2 associated with Andersen-Tawil syndromeC-W Lu, J-H Lin, Y S Rajawat, et al.

Zhonghua Fu Chan Ke Za Zhi|June 26, 2023

[Regional analysis of high risk factors of hypertensive disorders in pregnancy with organ or system impairment]X Lyu, W Y Zhang, J X Zhang, et al.

Bioorganic & Medicinal Chemistry Letters|July 29, 2000

Combinatorial diversification of indinavir: in vivo mixture dosing of an HIV protease inhibitor libraryT A Rano, Y Cheng, T T Huening, et al.

Current Drug Metabolism|July 24, 2001

Enzyme kinetics of cytochrome P450-mediated reactionsM Shou, Y Lin, P Lu, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2000

Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urineS K Balani, X Xu, B H Arison, et al.

Journal of Medical Virology|August 6, 2025

Modeling Antibody Kinetics Post-mRNA Booster Vaccination and Protection Durations Against SARS-CoV-2 InfectionLuis J Ponce, Yuqian Wang, Ananya Singh, et al.

Trials|June 16, 2022

Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]Xuan Ying Poh, I Russel Lee, Clarissa Lim, et al.

Pageof 43

Showing results (401-410 of 421) with videos related to

Sort By:

Pageof 43

Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|June 9, 2017

[Efficacy and safety of oseltamivir in children with suspected influenza: a multicenter randomized open-label trial]C H He, C Y Liu, G Y Lin, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1996

Species and organ differences in first-pass metabolism of the ester prodrug L-751,164 in dogs and monkeys. In vivo and in vitro studiesT Prueksaritanont, L M Gorham, J D Ellis, et al.

Zhonghua Fu Chan Ke Za Zhi|November 25, 2021

[Comparative analysis of high risk factors between early-onset pre-eclampsia and late-onset pre-eclampsia]X Lyu, W Y Zhang, J X Zhang, et al.

Journal of Medical Genetics|March 31, 2006

Functional and clinical characterization of a mutation in KCNJ2 associated with Andersen-Tawil syndromeC-W Lu, J-H Lin, Y S Rajawat, et al.

Zhonghua Fu Chan Ke Za Zhi|June 26, 2023

[Regional analysis of high risk factors of hypertensive disorders in pregnancy with organ or system impairment]X Lyu, W Y Zhang, J X Zhang, et al.

Bioorganic & Medicinal Chemistry Letters|July 29, 2000

Combinatorial diversification of indinavir: in vivo mixture dosing of an HIV protease inhibitor libraryT A Rano, Y Cheng, T T Huening, et al.

Current Drug Metabolism|July 24, 2001

Enzyme kinetics of cytochrome P450-mediated reactionsM Shou, Y Lin, P Lu, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2000

Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urineS K Balani, X Xu, B H Arison, et al.

Journal of Medical Virology|August 6, 2025

Modeling Antibody Kinetics Post-mRNA Booster Vaccination and Protection Durations Against SARS-CoV-2 InfectionLuis J Ponce, Yuqian Wang, Ananya Singh, et al.

Trials|June 16, 2022

Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]Xuan Ying Poh, I Russel Lee, Clarissa Lim, et al.

Pageof 43